Join
Live feed
·
INSIDERFilingvia Quantisnow
LENZ Therapeutics Inc. logo

Chief Financial Officer Chevallard Daniel R. bought $50,017 worth of shares (2,198 units at $22.76), increasing direct ownership by 69% to 5,386 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LENZ· LENZ Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LENZ (LENZ Therapeutics Inc.) and more on Quantisnow.